1
|
Garrocho-Rangel A, Cerda-Cristerna B, Pérez-Urizar J, Pozos-Guillén A. Tramadol loaded PLGA-microparticles for potential use in dentistry: Formulation and characterization. Dent Mater 2013. [DOI: 10.1016/j.dental.2013.08.066] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
2
|
Carrasco-Portugal MC, Granados-Soto V, Camacho-Vieyra GA, Pérez-Urizar J, Flores-Murrieta FJ. A SIMPLE METHOD FOR DETERMINATION OF NIMESULIDE IN RAT BLOOD SAMPLES BY HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY. J LIQ CHROMATOGR R T 2007. [DOI: 10.1081/jlc-100100485] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Affiliation(s)
- M. C. Carrasco-Portugal
- a Instituto Nacional de Pediatría , Secretaría de Salud, Apartado Postal 22026, México, D. F., 14000, Mexico
| | - V. Granados-Soto
- b Departamento de Farmacología y Toxicología, Centro de Investigación y de Estudios Avanzados , del Instituto Politécnico Nacional , Apartado Postal 22026, México, D. F., 14000, Mexico
| | - G. A. Camacho-Vieyra
- a Instituto Nacional de Pediatría , Secretaría de Salud, Apartado Postal 22026, México, D. F., 14000, Mexico
| | - J. Pérez-Urizar
- b Departamento de Farmacología y Toxicología, Centro de Investigación y de Estudios Avanzados , del Instituto Politécnico Nacional , Apartado Postal 22026, México, D. F., 14000, Mexico
| | - F. J. Flores-Murrieta
- c Departamento de Farmacología y Toxicología, Centro de Investigación y de Estudios Avanzados , del Instituto Politécnico Nacional , Apartado Postal 22026, México, D. F., 14000, Mexico
| |
Collapse
|
3
|
Pérez-Urizar J, Aguirre-Bañuelos P, Castañeda-Hernández G, Flores-Murrieta FJ. AN IMPROVED ASSAY BY HPLC WITH AMPEROMETRIC DETECTION FOR THE DETERMINATION OF PHENTOLAMINE IN PLASMA. J LIQ CHROMATOGR R T 2007. [DOI: 10.1081/jlc-100101472] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Affiliation(s)
- J. Pérez-Urizar
- Departamento de Farmacología y Toxicología, Centro de Investigación y de Estudios Avanzados del, Instituto Politécnico Nacional , Apartado Postal 22026, Mexico, D.F., 14000, Mexico
| | - P. Aguirre-Bañuelos
- Departamento de Farmacología y Toxicología, Centro de Investigación y de Estudios Avanzados del, Instituto Politécnico Nacional , Apartado Postal 22026, Mexico, D.F., 14000, Mexico
| | - G. Castañeda-Hernández
- Departamento de Farmacología y Toxicología, Centro de Investigación y de Estudios Avanzados del, Instituto Politécnico Nacional , Apartado Postal 22026, Mexico, D.F., 14000, Mexico
| | - F. J. Flores-Murrieta
- Departamento de Farmacología y Toxicología, Centro de Investigación y de Estudios Avanzados del, Instituto Politécnico Nacional , Apartado Postal 22026, Mexico, D.F., 14000, Mexico
| |
Collapse
|
4
|
Pérez-Urizar J, Picazo YF, Navarro-González B, Flores-Murrieta FJ, Castañeda-Hernández G. A New Rapid and Economical High Performance Liquid Chromatographic Assay with Electrochemical Detection for the Determination of Etoposide (VP-16) in Human Plasma Samples. J LIQ CHROMATOGR R T 2006. [DOI: 10.1080/10826079608001924] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
Affiliation(s)
- J. Pérez-Urizar
- a Sección de Terapéutica Experimental Departamento de Farmacología y Toxicología , Centro de Investigación y de Estudios Avanzados del I.P.N. México, D.F. , Mexico
| | - Y. F. Picazo
- a Sección de Terapéutica Experimental Departamento de Farmacología y Toxicología , Centro de Investigación y de Estudios Avanzados del I.P.N. México, D.F. , Mexico
| | - B. Navarro-González
- a Sección de Terapéutica Experimental Departamento de Farmacología y Toxicología , Centro de Investigación y de Estudios Avanzados del I.P.N. México, D.F. , Mexico
| | - F. J. Flores-Murrieta
- a Sección de Terapéutica Experimental Departamento de Farmacología y Toxicología , Centro de Investigación y de Estudios Avanzados del I.P.N. México, D.F. , Mexico
| | - G. Castañeda-Hernández
- a Sección de Terapéutica Experimental Departamento de Farmacología y Toxicología , Centro de Investigación y de Estudios Avanzados del I.P.N. México, D.F. , Mexico
| |
Collapse
|
5
|
Jiménez-Cardoso E, Flores-Luna A, Pérez-Urizar J. In vitro activity of two phenyl-carbamate derivatives, singly and in combination with albendazole against albendazole-resistant Giardia intestinalis. Acta Trop 2004; 92:237-44. [PMID: 15533293 DOI: 10.1016/j.actatropica.2004.08.003] [Citation(s) in RCA: 17] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/07/2004] [Revised: 08/05/2004] [Accepted: 08/13/2004] [Indexed: 11/28/2022]
Abstract
Giardia intestinalis is one of the most prevalent parasites in adults and children in Mexico. Benzimidazoles have been proposed as a therapeutic alternative in the treatment of giardiasis. However, high-dose related toxicity and the development of resistance have emerged in clinical trials using this therapy. In the search of alternative drugs, we found that benzimidazole-resistant strains of fungi have shown increased sensitivity to phenyl-carbamates, hence, we developed several substituted phenyl-carbamates, two of which were tested against the protozoan parasite G. intestinalis in susceptible and albendazole-resistant Giardia strains. 4-R-ethyl-phenyl-carbamates IRE-6A and IRE-7B demonstrated antigiardial, albeit modest, activity when compared with albendazole, against susceptible and albendazole-induced resistant Giardia. However, when albendazole 0.38 microg/mL (MIC(50)) was combined with each IRE compound, a significant antigiardial synergism (fractional inhibitory concentration index (FICI < 0.5)) was obtained not only with sensitive cultures but also with resistant Giardia parasites. The results described here suggest a potential role for a combined therapy with phenyl-carbamates and sub-doses of benzimidazoles in the treatment of giardiasis.
Collapse
Affiliation(s)
- E Jiménez-Cardoso
- Hospital Infantil de México Federico Gómez, SS, Dr. Márquez #162, Col. Doctores, C.P. 06720 México, D.F., Mexico.
| | | | | |
Collapse
|
6
|
Pérez-Urizar J, De Trocóniz IF, Ibarra AE, Flores-Murrieta FJ, Castañeda-Hernández G. A population model for tolmetin pharmacokinetics in rats considering saturable elimination. Proc West Pharmacol Soc 2001; 44:135-7. [PMID: 11793960] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 04/17/2023]
Affiliation(s)
- J Pérez-Urizar
- Sección Externa de Farmacología, CINVESTAV-IPN, México, D.F. 07360
| | | | | | | | | |
Collapse
|
7
|
Abstract
At present, pharmacokinetic-pharmacodynamic (PK-PD) modeling has emerged as a major tool in clinical pharmacology to optimize drug use by designing rational dosage forms and dosage regimes. Quantitative representation of the dose-concentration-response relationship should provide information for prediction of the level of response to a certain level of drug dose. Several mathematical approaches can be used to describe such relationships, depending on the single dose or the steady-state measurements carried out. With concentration and response data on-phase, basic models such as fixed-effect, linear, log-linear, E(MAX), and sigmoid E(MAX) can be sufficient. However, time-variant pharmacodynamic models (effect compartment, acute tolerance, sensitization, and indirect responses) can be required when kinetics and response are out-of-phase. To date, methodologies available for PK-PD analysis barely suppose the use of powerful computing resources. Some of these algorithms are able to generate individual estimates of parameters based on population analysis and Bayesian forecasting. Notwithstanding, attention must be paid to avoid overinterpreted data from mathematical models, so that reliability and clinical significance of estimated parameters will be valuable when underlying physiologic processes (disease, age, gender, etc.) are considered.
Collapse
Affiliation(s)
- J Pérez-Urizar
- Departamento de Farmacología y Toxicología, Centro de Investigación y de Estudios Avanzados del I.P.N. (CINVESTAV), Apdo. Postal 22026, 14000 Mexico City, Mexico.
| | | | | | | |
Collapse
|
8
|
Pérez-Urizar J, Granados-Soto V, Castañeda-Hernández G, Hong E, González C, Martínez JL, Flores-Murrieta FJ. Analgesic efficacy and bioavailability of ketorolac in postoperative pain: a probability analysis. Arch Med Res 2000; 31:191-6. [PMID: 10880726 DOI: 10.1016/s0188-4409(00)00050-3] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022]
Abstract
BACKGROUND The analgesic efficacy and bioavailability of 30 mg intramuscular ketorolac was studied in 24 patients with severe or very severe postoperative pain. METHODS Pain and pain relief were determined by a five-point verbal rating scale and data were submitted to a probability analysis. Ketorolac plasma levels were determined by high-performance liquid chromatography. RESULTS Two patients chose not to finish the study; 22 patients completed the study achieving at least good pain relief. Of these 22 patients, 13 reached complete pain relief. Ketorolac was rapidly absorbed. Notwithstanding, pain relief increased gradually, showing considerable delay with regard to plasma concentrations. Analysis of the probability-time curves revealed that 25% of the patients obtained moderate pain relief at 7 min after ketorolac administration, 50% at 11 min, 75% at 29 min, and 95% at 60 min. Good pain relief was achieved in 25, 50, and 75% of the patients at 1.1, 1.8, and 2.7 h, respectively. Complete pain relief was achieved in 25% and 50% of the patients at 2.6 h and 3.7 h, respectively. The probability of exhibiting an acceptable pain relief in responsive patients for more than 5 h was 0.97. No serious side effects were detected. CONCLUSIONS Results show that 30 mg intramuscular ketorolac is an adequate treatment for postoperative pain in the Mexican population. Therefore, the use of higher doses is not justified. Due to gradual installation of analgesia, administration of additional analgesic medication before 1 h is not recommended.
Collapse
MESH Headings
- Adult
- Analgesics, Non-Narcotic/administration & dosage
- Analgesics, Non-Narcotic/blood
- Analgesics, Non-Narcotic/pharmacokinetics
- Analgesics, Non-Narcotic/therapeutic use
- Anti-Inflammatory Agents, Non-Steroidal/administration & dosage
- Anti-Inflammatory Agents, Non-Steroidal/blood
- Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics
- Anti-Inflammatory Agents, Non-Steroidal/therapeutic use
- Biological Availability
- Chromatography, High Pressure Liquid
- Elective Surgical Procedures
- Female
- Humans
- Injections, Intramuscular
- Ketorolac/administration & dosage
- Ketorolac/blood
- Ketorolac/pharmacokinetics
- Ketorolac/therapeutic use
- Male
- Middle Aged
- Pain, Postoperative/blood
- Pain, Postoperative/drug therapy
- Treatment Outcome
Collapse
Affiliation(s)
- J Pérez-Urizar
- Departamento de Farmacología y Toxicología, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional (CINVESTAV del IPN), México, D.F., Mexico.
| | | | | | | | | | | | | |
Collapse
|
9
|
Abstract
The purpose of this study was to investigate sex-related differences in the pharmacokinetics of tolmetin, a potent nonsteroidal anti-inflammatory drug, in the rat. Male and female Wistar rats received oral tolmetin at two dose levels, 3.2 and 10 mg/kg. Blood samples were drawn at selected times after drug administration, and tolmetin concentration in whole blood was determined. Tolmetin was rapidly absorbed in all cases. C(max) increased with the dose, but was similar in both sexes. Notwithstanding, tolmetin half-life was significantly prolonged in females compared with males. As a result of the prolonged half-life, area under the curve values were significantly higher in females than in males. Tolmetin clearance was significantly reduced in females. The present results strongly suggest sex-related differences in the pharmacokinetics of tolmetin in the rat. Tolmetin elimination appears to be impaired in females, compared with males. The existence of sex-related differences in tolmetin pharmacokinetics in other species, including humans, requires further investigation.
Collapse
Affiliation(s)
- M Jiménez
- Facultad de Ciencias Químicas, Benemérita Universidad de Puebla, Mexico
| | | | | |
Collapse
|
10
|
Medeiros M, Pérez-Urizar J, Muñoz R, Castañeda-Hernández G. Limited sampling model for area-under-the-curve monitoring in pediatric patients receiving either Sandimmune or Neoral cyclosporin A oral formulations. Pediatr Transplant 1999; 3:225-30. [PMID: 10487284 DOI: 10.1034/j.1399-3046.1999.00037.x] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
Abstract
Several limited sampling equations were tested to predict the area under the curve (AUC) of cyclosporin A (CsA) at steady state in 10 children with end-stage renal disease receiving oral CsA 2.5 mg/kg b.i.d. as two different formulations, namely Sandimmune and Neoral, according to a randomized crossover design with a one-month washout period. AUC was significantly correlated with CsA concentration at 5 h. The equation derived from this single concentration time point was able to adequately predict the AUC for Sandimmune but not for Neoral. The equation derived from CsA concentration data, measured at 2 and 12 h, significantly improved predictive performance in terms of bias and precision, allowing adequate AUC predictions in both formulations. CsA concentration at 2 h was also able to predict Cmax, while the concentration at 12 h corresponded to the trough value in a b.i.d. dosing scheme. Therefore, it is concluded that a limited sampling model including concentration data at 2 and 12 h allows the estimation of AUC, Cmax and trough levels, yielding a complete profile in patients exposed to CsA as Sandimmune or Neoral. Hence, this model can be used for therapeutic monitoring of CsA levels in pediatric patients being switched from one formulation to another.
Collapse
Affiliation(s)
- M Medeiros
- Departamento de Nefrología, Hospital Infantil de México Federico Gómez, México, DF
| | | | | | | |
Collapse
|
11
|
Aguilar Ponce JL, Flores-Picazo Y, Pérez-Urizar J, Castañeda-Hernández G, Zinser-Sierra JW, Dueñas-González A, Calderón-Flores E, Segura-Pacheco BA, de la Garza-Salazar J. Bioavailability of etoposide after oral administration of the solution marketed for intravenous use: therapeutic and pharmacoeconomic perspectives. Arch Med Res 1999; 30:212-5. [PMID: 10427872 DOI: 10.1016/s0188-0128(99)00014-7] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
Abstract
BACKGROUND Oral etoposide administration is a suitable alternative to the intravenous route; therefore, commercial capsules have been developed. Before these capsules were available in Mexico, we studied drug bioavailability after oral administration of the intravenous etoposide solution (IVES). METHODS Eight adult cancer patients received a 50-mg oral etoposide dose as IVES and blood samples were collected over a period of 24 h. Plasma etoposide concentration was determined by high-performance liquid chromatography, plasma concentration against time curves were constructed, and bioavailability parameters were calculated. RESULTS Oral IVES yielded an adequate bioavailability profile because Cmax was 2.38 +/- 0.30 micrograms/mL, AUC was 12.87 +/- 2.02 micrograms/mL and half-life was 6.72 +/- 0.97 h. CONCLUSIONS Considering that the pharmacokinetic aim is to maintain plasma concentrations between 0.5 and 1.0 microgram/mL for several hours while avoiding high concentrations, i.e., of 10 micrograms/mL or higher, oral administration of 50-mg etoposide as IVES appears to be a suitable dosing option. In addition, oral IVES is considerably less expensive than intravenous administration in terms of both drug presentation and administration.
Collapse
|
12
|
Pérez-Urizar J, Aguirre-Bañuelos P, López-Muñoz FJ, Castañeda-Hernández G, Granados-Soto V. Activation of adenosine A1 receptors facilitates the analgesic effect of ketorolac and ketorolac-caffeine combinations in the rat. Proc West Pharmacol Soc 1999; 42:55-8. [PMID: 10697689] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 04/14/2023]
Affiliation(s)
- J Pérez-Urizar
- Departamento de Farmacología y Toxicología, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, México, D.F., Mexico
| | | | | | | | | |
Collapse
|
13
|
|
14
|
Flores-Murrieta FJ, Flores-Picazo Y, Pérez-Urizar J, Granados-Soto V, López-Muñoz FJ, Castañeda-Hernández G. Relationship between pharmacokinetics and the antinociceptive effect of indomethacin in the rat. Proc West Pharmacol Soc 1998; 40:111-3. [PMID: 9436229] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Affiliation(s)
- F J Flores-Murrieta
- Departamento de Farmacología y Toxicología, Centro de Investigación y de Estudios Avanzados, Instituto Politécnico Nacional, México, D.F., Mexico
| | | | | | | | | | | |
Collapse
|
15
|
Torres-López JE, Robles MB, Pérez-Urizar J, Flores-Murrieta FJ, Granados-Soto V. Determination of diclofenac in micro-whole blood samples by high-performance liquid chromatography with electrochemical detection. Application in a pharmacokinetic study. Arzneimittelforschung 1997; 47:1040-1043. [PMID: 9342419] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/22/2023]
Abstract
A rapid and sensitive method for the determination of diclofenac (CAS 15307-86-5) in whole blood samples by high-performance liquid chromatography with amperometric detection has been developed. This method was then used to study the pharmacokinetics of oral diclofenac sodium in the rat. The method includes a single extraction of acidified whole blood with ethyl acetate. Extracts were analyzed on a reversed-phase column eluted with a mixture of acetonitrile and 0.075 mol/l sodium acetate solution (pH 3.3) and detected amperometrically at + 1.1 V against Ag/AgCl. Retention times for diclofenac and the internal standard (naproxen) were 3.5 and 6 min, respectively. The method was linear in the range of 25 to 2000 ng/ml and the detection limit of the method was 10 ng/ml, using 100 microliters of whole blood sample. Employing this method, the oral pharmacokinetics of diclofenac in the rat was studied. Wistar male rats received an oral dose of 1, 3.2 or 10 mg/kg of diclofenac and blood samples were drawn at selected times during 12 h. After administration of diclofenac, a rapid increase of circulating concentrations was observed reaching a maximum in about 10 min. Then concentration decayed with a half-life of about 15 h. It is concluded that the method here reported is adequate for realization of pharmacokinetic studies of diclofenac in small species.
Collapse
Affiliation(s)
- J E Torres-López
- Departamento de Farmacología y Toxicología, Estudios Avanzados del Instituto Politécnico Nacional, Mexico City, Mexico
| | | | | | | | | |
Collapse
|
16
|
Abstract
The purpose of the present study was to examine the time dependence of oral paracetamol (acetaminophen) bioavailability in an experimental model of spinal cord injury (SCI). Female Sprague-Dawley rats were subjected to spinal cord contusion at the T8-T9 level by the weight drop method producing permanent paraplegia. Oral paracetamol bioavailability after administration of a single 100 mgkg-1 dose was determined 1, 12, and 50 d after SCI. Cmax and AUC were significantly decreased 1 d after SCI compared to sham-injured controls. This reduction, however, was temporary, as there was a recovery of bioavailability parameters which was partial 12 d after SCI, being complete by day 50. The present results confirm the usefulness of animal models for the characterization of the effect of SCI in drug kinetics. Data show that SCI induces significant changes in paracetamol pharmacokinetics. Nonetheless, despite the fact of a permanent loss of functions related to locomotion, pharmacokinetic alterations evolved with time.
Collapse
Affiliation(s)
- P García-López
- Departamento de Farmacología y Toxicología, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, México, D. F., Mexico
| | | | | | | | | |
Collapse
|
17
|
Hoyo-Vadillo C, Pérez-Urizar J, López-Munoz FJ. Usefulness of the pain-induced functional impairment model to relate plasma levels of analgesics to their efficacy in rats. J Pharm Pharmacol 1995; 47:462-5. [PMID: 7674128 DOI: 10.1111/j.2042-7158.1995.tb05831.x] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/26/2023]
Abstract
In this work we show that the pain-induced functional impairment model (PIFIR) can be used with cannulated rats as a useful procedure for pharmacokinetic/pharmacodynamic modelling. This model evaluates analgesia by measuring motor impairment of the right limb after intra-articular administration of uric acid. Time of contact with a rotating cylinder is referred to the control limb. We studied the pharmacokinetic and pharmacodynamics of naproxen after six peroral doses to Wistar rats, and we examined the adjuvant action of caffeine with naproxen. Surgery and blood sampling did not produce any difference on functional impairment either in rats without uric acid or in the dysfunction produced by uric acid. The relation between naproxen plasma concentration and the analgesic effect was obtained with few rats. Caffeine alone did not produce any significant modification in functional impairment but the co-administration significantly increased the effect of naproxen. Plasma levels of naproxen did not change when caffeine was co-administered. The PIFIR model with blood sampling is a suitable method for pharmacokinetic/pharmacodynamic relationship studies and is specially useful to characterize drug-drug interactions.
Collapse
Affiliation(s)
- C Hoyo-Vadillo
- Departamento de Farmacología y Toxicología, Centro de Investigación y de Estudios Avanzados, Instituto Politécnico Nacional, México DF, Mexico
| | | | | |
Collapse
|
18
|
Fernández-Guasti A, López-Rubalcava C, Pérez-Urizar J, Castañeda-Hernández G. Evidence for a postsynaptic action of the serotonergic anxiolytics: Ipsapirone, indorenate and buspirone. Brain Res Bull 1992; 28:497-501. [PMID: 1352175 DOI: 10.1016/0361-9230(92)90095-f] [Citation(s) in RCA: 20] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
Abstract
In the present experiment we analyzed whether the antianxiety action of the serotonergic 1A agonists buspirone (5 mg/kg), ipsapirone (5 mg/kg), indorenate (5 mg/kg), and 8-OH-DPAT (0.5 mg/kg) were mediated through the stimulation of pre- or postsynaptic serotonergic receptors. The experimental anxiety values were determined with the burying behavior test, where a reduction in the cumulative time of burying behavior was interpreted as a reduction in anxiety. To that purpose we analyzed the putative anxiolytic action of these drugs in animals with lesion of the serotonergic fibers after the intracerebroventricular (ICV) injection of 5,7-dihydroxytyptamine (5,7-DHT, 10 or 150 micrograms/10 microliters). The neurochemical analysis shows that these treatments produce a statistically significant reduction in 5-HT and 5-HIAA levels in various brain areas. The results of the behavioral experiments reveal that buspirone, ipsapirone, and indorenate produced exactly the same reduction in burying behavior in lesioned animals as compared with control rats. The reduction in burying behavior produced by 8-OH-DPAT was effectively prevented by the lesion with 5,7-DHT. These data suggest that the anxiolytic effect of buspirone, ipsapirone, and indorenate is mediated via the stimulation of postsynaptic receptors, while the somatodendritic receptors are involved in the antianxiety effect of 8-OH-DPAT.
Collapse
|